Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma
1 clinical trials · Condition
◉ Watch Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma
| Record | Firm | Date |
|---|---|---|
| Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies (NCT03739931) | ModernaTX, Inc. | 2018-11-27 |
Track Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.